KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Receivables - Net (2017 - 2025)

Historic Receivables - Net for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $4.5 million.

  • Bionano Genomics' Receivables - Net fell 1800.72% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 1800.72%. This contributed to the annual value of $4.9 million for FY2024, which is 4991.84% down from last year.
  • Latest data reveals that Bionano Genomics reported Receivables - Net of $4.5 million as of Q3 2025, which was down 1800.72% from $3.6 million recorded in Q2 2025.
  • Bionano Genomics' 5-year Receivables - Net high stood at $9.8 million for Q4 2023, and its period low was $3.5 million during Q1 2025.
  • Moreover, its 5-year median value for Receivables - Net was $5.6 million (2021), whereas its average is $6.1 million.
  • As far as peak fluctuations go, Bionano Genomics' Receivables - Net skyrocketed by 10266.67% in 2021, and later plummeted by 6039.35% in 2025.
  • Quarter analysis of 5 years shows Bionano Genomics' Receivables - Net stood at $5.6 million in 2021, then skyrocketed by 30.07% to $7.3 million in 2022, then skyrocketed by 34.0% to $9.8 million in 2023, then tumbled by 49.92% to $4.9 million in 2024, then dropped by 7.8% to $4.5 million in 2025.
  • Its Receivables - Net stands at $4.5 million for Q3 2025, versus $3.6 million for Q2 2025 and $3.5 million for Q1 2025.